keyword
MENU ▼
Read by QxMD icon Read
search

transaminase headache

keyword
https://www.readbyqxmd.com/read/27716337/clinical-and-paraclinical-profile-and-predictors-of-outcome-in-90-cases-of-scrub-typhus-meghalaya-india
#1
Sunuraj Sivarajan, Siddharudha Shivalli, Debomallya Bhuyan, Michael Mawlong, Rittwick Barman
BACKGROUND: India is an integral component of "tsutsugamushi triangle" which depicts a part of the globe endemic to scrub typhus. Owing to frequent outbreaks witnessed in different parts of the country in the recent past, scrub typhus is described as a re-emerging infectious disease in India. The present study aimed to study the clinical and paraclinical profile, complications and predictors of outcome among 90 cases of scrub typhus diagnosed in a hospital of north-eastern India from Sept 2011 to Aug 2012...
October 5, 2016: Infectious Diseases of Poverty
https://www.readbyqxmd.com/read/27694537/microangiopathic-antiphospholipid-antibody-associated-syndrome-in-a-pregnant-lady
#2
G S Kew, J Cho, A Lateef
We describe a gravid 37-year-old Chinese lady with known triple positive primary antiphospholipid syndrome with previous recurrent deep vein thrombosis and early spontaneous miscarriages. She was managed with low-molecular weight heparin, aspirin, hydroxychloroquine, prednisolone and monthly intravenous immunoglobulin.She presented with recurrent per-vaginal bleeding at 22 weeks of gestation and was found to have abruptio placentae. Anti-coagulation was held off. She subsequently delivered a stillborn at 24 weeks and anti-coagulation was restarted...
October 1, 2016: Lupus
https://www.readbyqxmd.com/read/27681546/clinico-laboratory-profile-of-dengue-patients-returning-from-tropical-areas-to-poland-during-2010-15
#3
A Kuna, M Bykowska, N Kulawiak, B Biernat, B Szostakowska, W L Nahorski, W Pawlowski, L Chomicz
BACKGROUND & OBJECTIVES: Dengue is a mosquito-borne viral disease, incidences of which have increased rapidly in the past decade. About 400 million new infections are recorded annually worldwide, and 40% of the human population lives in the areas at risk of dengue transmission. In this study, the clinical and laboratory profile of dengue diagnosed patients returning to Poland from tropical areas has been analyzed. METHODS: This is a retrospective study of 65 patients based on clinical symptoms and serological tests conducted in the Department of Tropical Parasitology of Institute of Maritime and Tropical Medicine (IMTM) in Gdynia, Poland during 2010-15...
July 2016: Journal of Vector Borne Diseases
https://www.readbyqxmd.com/read/27666901/clinical-and-laboratory-profile-of-dengue-fever
#4
Rajesh Deshwal, Md Ishaque Qureshi, Raj Singh
OBJECTIVE: Dengue fever is one of the most common arboviral mediated outbreaks reported with increased prevalence year after year with considerable morbidity and mortality. This study was designed to assess the clinical and biochemical parameters of dengue fever patients. METHODS: Prospective observational study was undertaken among adult patients in a military hospital. Five hundred fiteen patients were studied and analysed. All patients who were NS1 antigen/IgM dengue positive were included in the study...
December 2015: Journal of the Association of Physicians of India
https://www.readbyqxmd.com/read/27562743/weekends-off-efavirenz-based-antiretroviral-therapy-in-hiv-infected-children-adolescents-and-young-adults-breather-a-randomised-open-label-non-inferiority-phase-2-3-trial
#5
(no author information available yet)
BACKGROUND: For HIV-1-infected young people facing lifelong antiretroviral therapy (ART), short cycle therapy with long-acting drugs offers potential for drug-free weekends, less toxicity, and better quality-of-life. We aimed to compare short cycle therapy (5 days on, 2 days off ART) versus continuous therapy (continuous ART). METHODS: In this open-label, non-inferiority trial (BREATHER), eligible participants were aged 8-24 years, were stable on first-line efavirenz with two nucleoside reverse transcriptase inhibitors, and had HIV-1 RNA viral load less than 50 copies per mL for 12 months or longer...
September 2016: Lancet HIV
https://www.readbyqxmd.com/read/27508763/-op-5d-07-angiogenic-imbalanced-preeclampsia-versus-clinical-preeclampsia
#6
L Saleh, K Verdonk, A Kaya, A H Danser, A H van den Meiracker, W Visser
OBJECTIVE: The ratio of the maternal plasma angiogenic factors soluble Fms-kinase 1 (sFlt-1) and placental growth factor (PlGF) is a novel diagnostic tool for preeclampsia (PE), with a value <38 predicting short-term absence of PE in women in whom the syndrome is suspected clinically. The clinical implication of a single determination below the sFlt-1/PlGF ratio of 38 beyond 1 week remains to be established. We therefore assessed the evolution of the sFlt-1/PlGF ratio in patients suspected of PE on clinical grounds...
September 2016: Journal of Hypertension
https://www.readbyqxmd.com/read/26796768/outbreaks-of-brucellosis-related-to-the-consumption-of-unpasteurized-camel-milk
#7
Humberto G Garcell, Elias G Garcia, Pedro V Pueyo, Isis R Martín, Ariadna V Arias, Ramon N Alfonso Serrano
Brucellosis is the most frequent zoonosis reported in Qatar, mainly related to exposure to infected camels. An outbreak of human brucellosis in 14 members of a family living in a rural area in Qatar is reported herein. Clinical, epidemiological and laboratory results from all 14 patients with Brucella and 12 non-confirmed family members were collected from files. All patients reported fever for a maximum of 14 days, associated with arthralgia (6 patients), weakness (4 patients), headache (4 patients), diarrhea (2 patients) and abdominal pain (2 patients)...
July 2016: Journal of Infection and Public Health
https://www.readbyqxmd.com/read/26691901/tula-hantavirus-infection-in-a-hospitalised-patient-france-june-2015
#8
Jean Marc Reynes, Damien Carli, Nourredine Boukezia, Monique Debruyne, Samir Herti
We report an infection with Tula virus in June 2015, leading to hospitalisation, in a patient living approximately 60 km east of Paris with no previous remarkable medical history. Clinical symptoms were limited to a fever syndrome with severe headache. The main laboratory findings included thrombocytopenia and elevated transaminase levels. Based on S (small) gene sequence analysis, the strain affecting the patient was closely related to strains detected in Central Europe, especially to a south-east German strain...
2015: Euro Surveillance: Bulletin Européen sur les Maladies Transmissibles, European Communicable Disease Bulletin
https://www.readbyqxmd.com/read/26473751/vx-509-decernotinib-an-oral-selective-jak-3-inhibitor-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis
#9
RANDOMIZED CONTROLLED TRIAL
Mark C Genovese, Ronald F van Vollenhoven, César Pacheco-Tena, Yanqiong Zhang, Nils Kinnman
OBJECTIVE: To assess the efficacy and safety of decernotinib (VX-509), an oral selective inhibitor of JAK-3, in patients with rheumatoid arthritis (RA) in whom the response to methotrexate treatment was inadequate. METHODS: In this 24-week, double-blind, randomized phase IIb study, 358 patients with active RA received either placebo (n = 71) or VX-509 at dosages of 100 mg/day (n = 71), 150 mg/day (n = 72), 200 mg/day (n = 72), or 100 mg twice daily (n = 72)...
January 2016: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26374073/fda-approval-blinatumomab
#10
Donna Przepiorka, Chia-Wen Ko, Albert Deisseroth, Carolyn L Yancey, Reyes Candau-Chacon, Haw-Jyh Chiu, Brenda J Gehrke, Candace Gomez-Broughton, Robert C Kane, Susan Kirshner, Nitin Mehrotra, Tiffany K Ricks, Deborah Schmiel, Pengfei Song, Ping Zhao, Qing Zhou, Ann T Farrell, Richard Pazdur
On December 3, 2014, the FDA granted accelerated approval of blinatumomab (Blincyto; Amgen, Inc.) for treatment of Philadelphia chromosome-negative relapsed or refractory precursor B-cell acute lymphoblastic leukemia (R/R ALL). Blinatumomab is a recombinant murine protein that acts as a bispecific CD19-directed CD3 T-cell engager. The basis for the approval was a single-arm trial with 185 evaluable adults with R/R ALL. The complete remission (CR) rate was 32% [95% confidence interval (CI), 26%-40%], and the median duration of response was 6...
September 15, 2015: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
https://www.readbyqxmd.com/read/26261776/severe-scrub-typhus-infection-clinical-features-diagnostic-challenges-and-management
#11
REVIEW
John Victor Peter, Thomas I Sudarsan, John Anthony J Prakash, George M Varghese
Scrub typhus infection is an important cause of acute undifferentiated fever in South East Asia. The clinical picture is characterized by sudden onset fever with chills and non-specific symptoms that include headache, myalgia, sweating and vomiting. The presence of an eschar, in about half the patients with proven scrub typhus infection and usually seen in the axilla, groin or inguinal region, is characteristic of scrub typhus. Common laboratory findings are elevated liver transaminases, thrombocytopenia and leukocytosis...
August 4, 2015: World Journal of Critical Care Medicine
https://www.readbyqxmd.com/read/26090319/mediterranean-spotted-fever-case-series-of-24%C3%A2-years-1989-2012
#12
Pedro Crespo, Diana Seixas, Nuno Marques, Joaquim Oliveira, Saraiva da Cunha, A Meliço-Silvestre
PURPOSE: Mediterranean spotted fever (MSF) is the most prevalent zoonosis in Portugal. To characterize it's evolution between 1989 and 2012, the authors reviewed the cases diagnosed at their unit during this period. METHODS: Review of clinical records of patients with MSF diagnosis, between 1989 and 2012. RESULTS: Data from 250 patients was included, 54% male. Mean age at diagnosis was 58 years (11-92). Mean annual incidence was 10 cases, with clear summer predominance...
2015: SpringerPlus
https://www.readbyqxmd.com/read/25942723/fixed-dose-combination-therapy-with-daclatasvir-asunaprevir-and-beclabuvir-for-noncirrhotic-patients-with-hcv-genotype-1-infection
#13
MULTICENTER STUDY
Fred Poordad, William Sievert, Lindsay Mollison, Michael Bennett, Edmund Tse, Norbert Bräu, James Levin, Thomas Sepe, Samuel S Lee, Peter Angus, Brian Conway, Stanislas Pol, Nathalie Boyer, Jean-Pierre Bronowicki, Ira Jacobson, Andrew J Muir, K Rajender Reddy, Edward Tam, Grisell Ortiz-Lasanta, Victor de Lédinghen, Mark Sulkowski, Navdeep Boparai, Fiona McPhee, Eric Hughes, E Scott Swenson, Philip D Yin
IMPORTANCE: The antiviral activity of all-oral, ribavirin-free, direct-acting antiviral regimens requires evaluation in patients with chronic hepatitis C virus (HCV) infection. OBJECTIVE: To determine the rates of sustained virologic response (SVR) in patients receiving the 3-drug combination of daclatasvir (a pan-genotypic NS5A inhibitor), asunaprevir (an NS3 protease inhibitor), and beclabuvir (a nonnucleoside NS5B inhibitor). DESIGN, SETTING, AND PARTICIPANTS: This was an open-label, single-group, uncontrolled international study (UNITY-1) conducted at 66 sites in the United States, Canada, France, and Australia between December 2013 and August 2014...
May 5, 2015: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/25926620/randomized-controlled-trial-of-the-cgrp-receptor-antagonist-telcagepant-for-prevention-of-headache-in-women-with-perimenstrual-migraine
#14
RANDOMIZED CONTROLLED TRIAL
Tony W Ho, Andrew P Ho, Yang Joy Ge, Christopher Assaid, Regina Gottwald, E Anne MacGregor, Lisa K Mannix, Willebrordus P J van Oosterhout, Janelle Koppenhaver, Christopher Lines, Michel D Ferrari, David Michelson
AIM: The aim of this article is to evaluate the safety and efficacy of perimenstrual telcagepant, a CGRP receptor antagonist, for headache prophylaxis. METHODS: We conducted a randomized, double-blind, placebo-controlled, six-month trial in women with migraine for ≥ 3 months who experienced perimenstrual headaches. Women were randomized to telcagepant 140 mg or placebo (2:1 ratio) for seven consecutive days perimenstrually. Safety was assessed by adverse events and laboratory tests...
February 2016: Cephalalgia: An International Journal of Headache
https://www.readbyqxmd.com/read/25891462/-analysis-of-clinical-characteristic-of-158-inpatients-with-dengue-fever-in-guangzhou-area-during-the-2014-epidemic
#15
Zi Ye, Yingxiong Huang, Peng Jiang, Ziyu Zheng, Yan Xiong, Jia Xu, Xiaoyong Xiao, Hong Zhan
OBJECTIVE: To investigate the clinical characteristics of the inpatients suffering from dengue fever in order to provide references for better diagnosis and treatment. METHODS: The clinical data of 158 dengue fever patients admitted to the First Affiliated Hospital of Sun Yat-Sen University from July 23rd to October 31st, 2014 during the 2014 epidemic in Guangzhou area were retrospectively analyzed, including general clinical manifestations, conventional examinations, pathogenesis, and prognosis...
April 2015: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
https://www.readbyqxmd.com/read/25889074/clinical-profile-of-plasmodium-falciparum-and-plasmodium-vivax-infections-in-low-and-unstable-malaria-transmission-settings-of-colombia
#16
Myriam Arévalo-Herrera, Mary Lopez-Perez, Luz Medina, Alberto Moreno, Juan B Gutierrez, Sócrates Herrera
BACKGROUND: Malaria transmission in Latin America is generally hypoendemic and unstable, with Plasmodium vivax as the most prevalent species. However, only a few studies have been carried out in areas with low and unstable transmission, whereas the clinical profile of malaria has been broadly described in hyperendemic areas. The pattern of clinical manifestations and laboratory findings in low to moderate endemic areas of Colombia is reported here. METHODS: A passive surveillance study was conducted between 2011 and 2013 involving 1,328 patients with Plasmodium falciparum, P...
2015: Malaria Journal
https://www.readbyqxmd.com/read/25837829/ombitasvir-plus-paritaprevir-plus-ritonavir-with-or-without-ribavirin-in-treatment-naive-and-treatment-experienced-patients-with-genotype-4-chronic-hepatitis-c-virus-infection-pearl-i-a-randomised-open-label-trial
#17
RANDOMIZED CONTROLLED TRIAL
Christophe Hézode, Tarik Asselah, K Rajender Reddy, Tarek Hassanein, Marina Berenguer, Katarzyna Fleischer-Stepniewska, Patrick Marcellin, Coleen Hall, Gretja Schnell, Tami Pilot-Matias, Niloufar Mobashery, Rebecca Redman, Regis A Vilchez, Stanislas Pol
BACKGROUND: Hepatitis C virus (HCV) genotype 4 accounts for about 13% of global HCV infections. Because interferon-containing treatments for genotype 4 infection have low efficacy and poor tolerability, an unmet need exists for effective all-oral regimens. We examined the efficacy and safety of an all-oral interferon-free regimen of ombitasvir, an NS5A inhibitor, and paritaprevir (ABT-450), an NS3/4A protease inhibitor dosed with ritonavir (ombitasvir plus paritaprevir plus ritonavir), given with or without ribavirin...
June 20, 2015: Lancet
https://www.readbyqxmd.com/read/25764452/adverse-events-of-anti-tumor-necrosis-factor-%C3%AE-therapy-in-ankylosing-spondylitis
#18
Qiang Tong, Qing Cai, Tristan de Mooij, Xia Xu, Shengming Dai, Wenchun Qu, Dongbao Zhao
OBJECTIVE: This study aims to investigate the prevalence of short-term and long-term adverse events associated with tumor necrosis factor-α (TNF-α) blocker treatment in Chinese Han patients suffering from ankylosing spondylitis (AS). METHODS: The study included 402 Chinese Han AS patients treated with TNF-α blockers. Baseline data was collected. All patients were monitored for adverse events 2 hours following administration. Long-term treatment was evaluated at 8, 12, 52 and 104 weeks follow-up for 172 patients treated with TNF-α blockers...
2015: PloS One
https://www.readbyqxmd.com/read/25760671/clinical-drug-interaction-profile-of-idelalisib-in-healthy-subjects
#19
Feng Jin, Michelle Robeson, Huafeng Zhou, Candra Moyer, Sibylle Wilbert, Bernard Murray, Srini Ramanathan
Idelalisib, a potent phosphatidylinositol-3-kinase delta (PI3Kδ) inhibitor, is metabolized primarily by aldehyde oxidase to form GS-563117 and to a lesser extent by cytochrome P450 (CYP) 3A and uridine 5'-diphospho-glucuronosyltransferase 1A4. In vitro, idelalisib inhibits P-glycoprotein (P-gp) and organic anion transporting polypeptides 1B1 and 1B3, and GS-563117 is a time-dependent CYP3A inhibitor. This study enrolled 24 healthy subjects and evaluated (1) the effect of idelalisib on the pharmacokinetics (PK) of digoxin, a P-gp probe substrate, rosuvastatin, a breast cancer resistance protein, and OATP1B1/OATP1B3 substrate, and midazolam, a CYP3A substrate; and (2) the effect of a strong inducer, rifampin, on idelalisib PK...
August 2015: Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/25732608/efficacy-and-safety-of-acetylcysteine-in-non-acetaminophen-acute-liver-failure-a-meta-analysis-of-prospective-clinical-trials
#20
Jinhua Hu, Qizhi Zhang, Xingye Ren, Ziqin Sun, Qizhen Quan
BACKGROUND: Acute liver failure (ALF) is a rare but highly mortal condition without liver transplantation (LT). N-acetylcysteine (NAC), a glutathione precursor that detoxifies the reactive metabolite of acetaminophen and replenishes hepatic glutathione stores, is a highly effective drug for the prevention of ALF caused by acetaminophen. However, therapeutic use of NAC in non-acetaminophen-induced ALF (NAI-ALF) including alcohol intoxication, hepatitis virus infection, or drug and toxin-related hepatotoxicity is still inconclusive...
October 2015: Clinics and Research in Hepatology and Gastroenterology
keyword
keyword
111333
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"